US Stock MarketDetailed Quotes

PALI Palisade Bio

Watchlist
  • 0.8899
  • -0.0566-5.98%
Close Feb 25 16:00 ET
  • 0.9343
  • +0.0444+4.99%
Post 20:01 ET
2.46MMarket Cap-0.07P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Palisade Bio (PALI.US)$
    Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada's SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
    Thursday, 20th February at 8:45 am
    Company through its co-development partner, Giiant Pharma, Inc. ("Giiant"), receives funding from Canadian Scientific Research and Experimental Development (SR&ED) Tax Credit Program for PALI-2108
    Ongoing progress of Palisade Bio's Phase 1a/b UC st...
    $Palisade Bio (PALI.US)$ Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
    2 MINUTES AGO, 8:45 AM EST
    VIA GLOBENEWSWIRE
    Data presented at the 2025 Crohn's and Colitis Congress 
    PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure
    Company advancing Phase 1a/b study of PALI-2108 and has demonstrated a favorable safety profile in single-ascending-dose cohorts
    $Palisade Bio (PALI.US)$
    Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
    Monday, 10th February at 8:45 am
    Data presented at the 2025 Crohn's and Colitis Congress 
    PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure
    Company advancing Phase 1a/b study of PALI-2108 and has demonstrated a favorable safety profile in single-ascending-dose cohorts
    Carlsbad, CA, Fe...
Read more

Trending Stocks

Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Show More